Drugs for malaria or antimalarial medications are also known as anti-malarial drugs. Anti-malarial drugs treat or Prevention malaria, a disease that occurs in tropical, subtropical, and some temperate regions of the world. The disease is caused by a parasite, Plasmodium, which belongs to a group of one-celled organisms known as protozoa. The only way to get malaria is to be bitten by a certain type of mosquito that has bitten someone who has the disease. Scope of the Report: This report focuses on the Drugs for Malaria in Europe market, especially in Germany, UK, France, Russia, and Italy. This report categorizes the market based on manufacturers, countries, type and application. Market Segment by Manufacturers, this report covers Cipla Guilin Pharmaceutical IPCA Laboratories GlaxoSmithKline Mylan Labs Roche Novartis Sanofi Aventis Ajanta Pharma Market Segment by Countries, covering Germany UK France Russia Italy Market Segment by Type, covers Aryl Aminoalcohol Compounds Antifolate Compounds Artemisinin Compounds Market Segment by Applications, can be divided into Prevention Treatment Other There are 17 Chapters to deeply display the Europe Drugs for Malaria market. Chapter 1, to describe Drugs for Malaria Introduction, product type and application, market overview, market analysis by countries, market opportunities, market risk, market driving force; Chapter 2, to analyze the manufacturers of Drugs for Malaria, with profile, main business, news, sales, price, revenue and market share in 2016 and 2017; Chapter 3, to display the competitive situation among the top manufacturers in Europe, with sales, revenue and market share in 2016 and 2017; Chapter 4, to show the Europe market by countries, covering Germany, UK, France, Italy and Russia, with sales, price, revenue and market share of Drugs for Malaria, for each country, from 2012 to 2017; Chapter 5 and 6, to show the market by type and application, with sales, price, revenue, market share and growth rate by type and application, from 2012 to 2017; Chapter 7, 8, 9, 10 and 11, to analyze the key countries by manufacturers, Type and Application, covering Germany, UK, France, Italy and Russia, with sales, revenue and market share by manufacturers, types and applications; Chapter 12, Drugs for Malaria market forecast, by countries, type and application, with sales, price, revenue and growth rate forecast, from 2017 to 2022; Chapter 13, to analyze the manufacturing cost, key raw materials and manufacturing process etc. Chapter 14, to analyze the industrial chain, sourcing strategy and downstream end users (buyers); Chapter 15, to describe Drugs for Malaria sales channel, distributors, traders, dealers etc. Chapter 16 and 17, to describe Drugs for Malaria Research Findings and Conclusion, Appendix, methodology and data source
Table of Contents 1 Market Overview 1.1 Drugs for Malaria Introduction 1.2 Market Analysis by Type 1.2.1 Aryl Aminoalcohol Compounds 1.2.2 Antifolate Compounds 1.2.3 Artemisinin Compounds 1.3 Market Analysis by Applications 1.3.1 Prevention 1.3.2 Treatment 1.3.3 Other 1.4 Market Analysis by Countries 1.4.1 Germany
